EP1001966A4 - Ein senescene-gen und seine verwendung zur behandlung von krebs und anderen krankheiten - Google Patents

Ein senescene-gen und seine verwendung zur behandlung von krebs und anderen krankheiten

Info

Publication number
EP1001966A4
EP1001966A4 EP98933073A EP98933073A EP1001966A4 EP 1001966 A4 EP1001966 A4 EP 1001966A4 EP 98933073 A EP98933073 A EP 98933073A EP 98933073 A EP98933073 A EP 98933073A EP 1001966 A4 EP1001966 A4 EP 1001966A4
Authority
EP
European Patent Office
Prior art keywords
senescene
gene
diseases
treating cancer
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98933073A
Other languages
English (en)
French (fr)
Other versions
EP1001966A1 (de
Inventor
Olivia M Pereira-Smith
Yi Ning
Michael J Bertram
Nathalie Berube
Xin Swanson
James K Leung
Qitao Ran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of EP1001966A1 publication Critical patent/EP1001966A1/de
Publication of EP1001966A4 publication Critical patent/EP1001966A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98933073A 1997-07-03 1998-07-02 Ein senescene-gen und seine verwendung zur behandlung von krebs und anderen krankheiten Withdrawn EP1001966A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5162697P 1997-07-03 1997-07-03
US51626P 1997-07-03
US98584597A 1997-12-05 1997-12-05
US985845 1997-12-05
PCT/US1998/013743 WO1999001465A1 (en) 1997-07-03 1998-07-02 A senescence gene and its use in the treatment of cancer and other diseases

Publications (2)

Publication Number Publication Date
EP1001966A1 EP1001966A1 (de) 2000-05-24
EP1001966A4 true EP1001966A4 (de) 2002-09-18

Family

ID=26729652

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98933073A Withdrawn EP1001966A4 (de) 1997-07-03 1998-07-02 Ein senescene-gen und seine verwendung zur behandlung von krebs und anderen krankheiten

Country Status (3)

Country Link
EP (1) EP1001966A4 (de)
AU (1) AU8282498A (de)
WO (1) WO1999001465A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102225645B1 (ko) * 2018-12-21 2021-03-22 주식회사 마크로젠 노화 특이적 바이오마커
WO2022135486A1 (zh) * 2020-12-22 2022-06-30 中国科学院动物研究所 鉴定和/或调节衰老的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 2 April 1993 (1993-04-02), OHARA ET AL.: "Human mRNA for KIAAA0026 gene, complete cds", XP002206665, Database accession no. D14812 *

Also Published As

Publication number Publication date
AU8282498A (en) 1999-01-25
EP1001966A1 (de) 2000-05-24
WO1999001465A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
ATE347360T1 (de) Verfahren zur induktion von krebszellentod und tumorregression
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
EP1037625A4 (de) Verfahren zur herstellung von arsentrioxyd-formulierungen und verfahren zur behandlung von krebs mit arsentrioxyd oder melarsoprol
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69900249D1 (de) Pharmazeutische zusammensetzung von metformin und fibrat, und ihre verwendung zur behandlung von hyperglykämie
DE69810584D1 (de) Verfahren und Methode zur Behandlung von Abfällen
DE69612649D1 (de) Indolinonverbindungen zur behandlung von krankheiten
ATE235236T1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE60013859D1 (de) Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis
ATE231686T1 (de) Schädlingsbekämpfungsmittel zur behandlung von saatgut
DE69414916D1 (de) Mittel zur Entfernung von farbigem Material und seine Verwendung
DE69526935D1 (de) Verwendung von mycobacterium zur tumorbehandlung
DE69637579D1 (de) Methode zur Amplifizierung von Nukleinsäure und entsprechende Regenzien dafür
DE69801290D1 (de) Metallisches Material mit photokatalytischer Aktivität und Verfahren zur Herstellung
EP1109548A4 (de) Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
ATE254128T1 (de) Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE59508509D1 (de) Dna-expressionsvektoren zur verwendung in der gentherapeutischen behandlung von gefässerkrankungen
EP1001966A4 (de) Ein senescene-gen und seine verwendung zur behandlung von krebs und anderen krankheiten
DE69736376D1 (de) Material zur tierabfallbehandlung und verfahren zur dessen herstellung
ATE433323T1 (de) Verwendung von erythropoietin zur behandlung von primärer hämochromatosen
DE69937365D1 (de) Verfahren zur verwendung von aralkylsiloxanen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000203

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RAN, QITAO

Inventor name: LEUNG, JAMES K.

Inventor name: SWANSON, XIN

Inventor name: BERUBE, NATHALIE

Inventor name: BERTRAM, MICHAEL, J.

Inventor name: NING, YI

Inventor name: PEREIRA-SMITH, OLIVIA, M.

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RAN, QITAO

Inventor name: LEUNG, JAMES K.

Inventor name: SWANSON, XIN

Inventor name: BERUBE, NATHALIE

Inventor name: BERTRAM, MICHAEL, J.

Inventor name: NING, YI

Inventor name: PEREIRA-SMITH, OLIVIA, M.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07H 21/04 A, 7A 61K 48/00 B, 7C 07K 14/00 B, 7C 07K 16/00 B, 7C 12Q 1/68 B, 7C 07K 14/47 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020802

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

18D Application deemed to be withdrawn

Effective date: 20000204